$AMWL

McNeice Paul Francis sold $1K of AMWL

McNeice Paul Francis (Chief Accounting Officer) sold 112 shares of American Well Corp (AMWL) at $9.74 on 2026-06-01.

Original reporting
SEC EDGAR · McNeice Paul Francis
Published Jun 3, 2026, 8:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMWL
Neutral
high confidence
Mentioned
$AMWL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMWLNeutralLow
01

Why it matters

The disclosure updates the insider-trading record but does not introduce new operational, financial, or regulatory information.

02

Market read

Traders may note the insider sale for sentiment monitoring, but it is unlikely to drive a fundamental repricing on its own.

03

What to watch

Insider sales can be driven by taxes, diversification, or pre-scheduled personal needs; without context on total holdings/compensation, directional inference is weak.

Relevance 4/10Novelty 7/10Timing: Filed 2026-06-03; sale occurred 2026-06-01

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct holdings) for American Well Corp.

Company-level read

Ticker impact

$AMWLNeutralHigh confidence
Context

Chief Accounting Officer McNeice Paul Francis sold 112 shares of AMWL on 2026-06-01, disclosed via SEC Form 4.

Expected impact

Limited near-term impact; any reaction is likely small and sentiment-driven.

Evidence & confidence

The filing is a routine Form 4 insider transaction with small absolute value (~$1.1k) and no accompanying corporate event or guidance change.

Market effects

No clear sector read-through; this is company-specific insider activity without broader industry catalyst.

None.

None.

Counterpoint

The sale may be routine liquidity/compensation-related and not a bearish signal, especially given the lack of a 10b5-1 plan mention and small dollar amount.

Key entities

  • American Well Corp

    Subject of the Form 4 insider transaction disclosure.

  • McNeice Paul Francis

    Chief Accounting Officer who sold AMWL shares.

Related articles

$QTTBMedAI 8/10

Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus

Biotech gainers highlighted Q32 Bio (QTTB), up 90.7% to $21.38 after positive Phase 2 SIGNAL-AA results for bempikibart in alopecia areata, and it launched a $200M underwritten stock offering. Agenus (AGEN) rose 82.7% to $6.12 on a planned ~$85M private placement for BOT+BAL Phase 3 ROBBIN1. Other movers: ACTU, GALT, AMWL, SI.